United Kingdom – One of the world’s largest pharmaceutical companies, GSK, will be a Principal Partner for the vital climate change summit, COP26, taking place in Glasgow later this year.
GSK is the ninth Principal Partner who will support the delivery of a successful and ambitious COP26. The company joins SSE, ScottishPower, NatWest Group, National Grid, Sky, Sainsbury’s, Hitachi and Reckitt.
Through these partnerships, the COP26 Presidency is showing a clear commitment to working with businesses who are taking real steps towards net zero.
GSK is already committed to science-based targets and last year announced environmental sustainability goals in both climate and nature, aiming to have a net zero impact on climate and a net positive impact on nature by 2030.
During the period of its COP26 partnership, GSK will work with partners to drive action in areas such as improving understanding of the impact of climate change and nature loss on health, and supporting the Race to Zero in the life sciences sector.
COP President Alok Sharma said:
“With less than six months to go until COP26, I am delighted to welcome GSK as a Principal Partner for the summit in Glasgow.
“Businesses have a key role to play in helping us ensure COP26 is a success and I look forward to working with GSK as we continue our work ahead of the summit in November.”
GSK Chief Executive, Emma Walmsley, said:
“As a global science-based healthcare company, we want to play our part in helping protect and restore the planet’s health, in order to protect and improve people’s health. We know that taking actions to do so will make our business more resilient and support growth in the long term.
“We strongly believe that COP26 must accelerate global actions and collaborations to protect climate, nature and health and we are delighted to support the UK government with their ambitions for a successful COP26.”